Latest News in the pharma Industry

Top Stories

Medicia to distribute Injex 30 in Russia

Medicia to distribute Injex 30 in Russia

10 Oct 2012

A new distributor contract has been signed between Injex Pharma and Medicia.

Read more 
New excipients on show at CPhl Worldwide in Madrid

New excipients on show at CPhl Worldwide in Madrid

10 Oct 2012

New excipients will be on show at a pharmaceuticals event in Madrid later this month.

Read more 
AMRI Announces Strategic Contract with Knopp Biosciences

AMRI Announces Strategic Contract with Knopp Biosciences

8 Oct 2012

SMARTSOURCING™ Agreement Strengthens Existing Relationship

Read more 
BASF opens new topical formation lab in NY

BASF opens new topical formation lab in NY

3 Oct 2012

BASF has announced the opening of a global dermatology lab in New York where topical formations will be developed for the pharmaceutical market.

Read more 
Brazil delays new rules for governing excipients

Brazil delays new rules for governing excipients

3 Oct 2012

Brazil's national medicines regulator has pushed back the implementation of proposed new rules that would govern the manufacturing of excipients.

Read more 
PANREAC presents a new line of excipients for the pharmaceutical industry according to the IPEC guide

PANREAC presents a new line of excipients for the pharmaceutical industry according to the IPEC guide

26 Sep 2012

PANREAC specialized in the manufacturing of reagents for laboratory analysis, excipients and bulk chemicals to be used as raw materials in the pharmaceutical, cosmetic and food industries.

Read more 
Panreac presents its synthesis product line

Panreac presents its synthesis product line

26 Sep 2012

Panreac Synthesis is the business unit of PANREAC, the Spanish leader company in manufacturing reagents, solvents and fine chemicals since 1941.

Read more 
Big pharma collaborate to speed up drug development

Big pharma collaborate to speed up drug development

24 Sep 2012

TransCelerate BioPharma is a non-profit organisation set up by ten biopharmaceutical giants.

Read more 
Cardiolynx Receives Patent on Improved Angina Pectoris Drug

Cardiolynx Receives Patent on Improved Angina Pectoris Drug

20 Sep 2012

Cardiolynx Ltd., specializing in the development of improved cardio-metabolic therapies, announces that the European Patent Office (EPO) has granted a patent covering a new chemical entity, CLC-1280, developed using Cardiolynx' nitric oxide technology.

Read more 
Mucosis Appoints Thomas Johnston to CEO

Mucosis Appoints Thomas Johnston to CEO

18 Sep 2012

Mucosis B.V., the Dutch clinical-stage biotechnology company developing mucosal vaccines, today announced the appointment of Thomas Johnston to the position of Chief Executive Officer, effective immediately.

Read more 
RepliGen Europe Limited withdraws its marketing authorisation application for SecreFlo (secretin human)

RepliGen Europe Limited withdraws its marketing authorisation application for SecreFlo (secretin human)

17 Sep 2012

The European Medicines Agency has been formally notified by RepliGen Europe Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicine SecreFlo (secretin human).

Read more 
Committee for Orphan Medicinal Products elects new chair and vice-chair

Committee for Orphan Medicinal Products elects new chair and vice-chair

17 Sep 2012

At its September 2012 meeting, the European Medicines Agency's Committee for Orphan Medicinal Products (COMP) elected Professor Bruno Sepodes from Portugal as its chair and Ms Lesley Greene, a volunteer patient representative for Eurordis, as its vice-...

Read more